Atrium Therapeutics, Inc.
Ticker: 2093101
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q1 FY2025 |
|---|---|---|
| INCOME | ||
| Revenue | 19.64+1151.0% | 1.57 |
| Total Income | 19.64+1151.0% | 1.57 |
| EXPENSES | ||
| Expenditure | 36.92+308.9% | 9.03 |
| PROFIT | ||
| Net Profit | -16.63-123.2% | -7.45 |
| KEY METRICS | ||
| OPM % | -88.01%+11.99pp | -100.00% |
| NPM % | -84.71%+15.29pp | -100.00% |
| EPS | -0.97-120.5% | -0.44 |
Corporate Events
No corporate events found.